Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Biotech
FDA considers new liver trial endpoint, sending MASH shares up
The FDA has begun considering a noninvasive diagnostic measure for patients with fatty liver disease, a move that could speed up drug development.
Gabrielle Masson
Aug 28, 2025 11:25am
Novo seeks obesity refresh with $550M Replicate deal
Aug 28, 2025 7:00am
Paul Allen research foundation unveils with $500M funding plan
Aug 27, 2025 11:59am
Chinese CRO ChemPartner gets ready to debut US research facility
Aug 26, 2025 2:57pm
Lineage tunes up hearing loss transplant with $12M research pact
Aug 26, 2025 11:00am
Novartis pens BioArctic neuro pact worth $30M upfront
Aug 26, 2025 8:30am
